HTG MOLECULAR DIAGNOSTICS, INC Contracts & Agreements

Form of Series A-1 Warrant to Purchase Common Stock, issued on December 23, 2022 (Filed With SEC on December 23, 2022)

Form of Series A-2 Warrant to Purchase Common Stock, issued on December 23, 2022 (Filed With SEC on December 23, 2022)

Form of Pre-funded Warrant to Purchase Common Stock, issued on December 23, 2022 (Filed With SEC on December 23, 2022)

Form of Placement Agent Warrant, issued on December 23, 2022 (Filed With SEC on December 23, 2022)

Form of Common Stock Certificate of the Registrant (Filed With SEC on December 21, 2022)

Form of Series A-1 and Series A-2 Warrant to Purchase Common Stock (Filed With SEC on December 21, 2022)

Form of Pre-Funded Warrant to Purchase Common Stock (Filed With SEC on December 21, 2022)

Form of Placement Agent Warrant (Filed With SEC on December 21, 2022)

Form of Securities Purchase Agreement (Filed With SEC on December 21, 2022)

Second Amendment to Loan and Security Agreement, dated September 8, 2022, by and between Silicon Valley Bank and the Company (Filed With SEC on November 10, 2022)

Purchase Agreement, dated October 21, 2022, by and between HTG Molecular Diagnostics, Inc. and the purchaser named therein (Filed With SEC on October 21, 2022)

First Amendment to Loan and Security Agreement, dated July 14, 2022, by and between Silicon Valley Bank and the Company (Filed With SEC on July 18, 2022)

Description of Common Stock (Filed With SEC on March 29, 2022)

Form of Pre-Funded Warrant (Filed With SEC on March 21, 2022)

Form of Common Stock Warrant (24-month term) (Filed With SEC on March 21, 2022)

Form of Common Stock Warrant (66-month term) (Filed With SEC on March 21, 2022)

Registration Rights Agreement, dated as of March 17, 2022, between HTG Molecular Diagnostics, Inc. and the purchaser party thereto (Filed With SEC on March 21, 2022)

Third Amendment, dated September 27, 2021, to Standard Commercial-Industrial Multi Tenant Triple Net Lease, dated July 11, 2008, between the Company and Pegasus Properties L.P (Filed With SEC on September 29, 2021)

Fourth Amendment, dated September 27, 2021, to Standard Commercial-Industrial Multi Tenant Triple Net Lease, dated May 11, 2011, between the Company and Pegasus Properties L.P (Filed With SEC on September 29, 2021)

HTG Molecular Diagnostics, Inc. Amended and Restated 2014 Employee Stock Purchase Plan (Filed With SEC on August 19, 2021)

Form of Common Stock Certificate of the Registrant (Filed With SEC on March 25, 2021)

Description of Capital Stock (Filed With SEC on March 25, 2021)

HTG Molecular Diagnostics, Inc. Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 25, 2021)

HTG Molecular Diagnostics, Inc. Severance and Change in Control Plan (Filed With SEC on March 25, 2021)

Second Amendment to Lease Agreement (Suite 300 Laboratory), dated December 8, 2020, by and between the Registrant and Pegasus Properties, L.P (Filed With SEC on March 25, 2021)

Third Amendment to Lease Agreement (Suite 100 Administration), dated December 8, 2020, by and between the Registrant and Pegasus Properties, L.P (Filed With SEC on March 25, 2021)

HTG Molecular Diagnostics, Inc. 2020 Equity Incentive Plan (Filed With SEC on August 20, 2020)

Warrant to Purchase Common Stock, issued to Silicon Valley Bank on June 24, 2020 (Filed With SEC on June 25, 2020)

Loan and Security Agreement, dated June 24, 2020, by and among the Company and Silicon Valley Bank (Filed With SEC on June 25, 2020)

Description of Capital Stock (Filed With SEC on March 25, 2020)

Amendment No. 1 to Credit and Security Agreement (Term Loan) by and among the Registrant, the lenders party thereto from time to time and MidCap Financial Trust, as agent, dated... (Filed With SEC on March 25, 2020)

Amendment No. 1 to Credit and Security Agreement (Revolving Loan) by and among the Registrant, the lenders party thereto from time to time and MidCap Funding IV Trust (assignee of... (Filed With SEC on March 25, 2020)

Amendment No. 2 to Credit and Security Agreement (Revolving Loan) by and among the Registrant, the lenders party thereto from time to time and MidCap Funding IV Trust (assignee of... (Filed With SEC on March 25, 2020)

Employment Agreement, dated July 28, 2019, by and between Byron Lawson and the Registrant (Filed With SEC on March 25, 2020)

Purchase Agreement, dated as of March 24, 2020, by and between the Company and Lincoln Park (Filed With SEC on March 25, 2020)

Registration Rights Agreement, dated as of March 24, 2020, by and between the Company and Lincoln Park (Filed With SEC on March 25, 2020)

Amendment No. 2 to Credit and Security Agreement (Term Loan), dated February 26, 2020, by and among the Company, the lenders party thereto and MidCap Financial Trust, as agent (Filed With SEC on February 27, 2020)

Amendment No. 3 to Credit and Security Agreement (Revolving Loan), dated February 26, 2020, by and among the Company, the lenders party thereto and MidCap Funding IV Trust, as... (Filed With SEC on February 27, 2020)

Controlled Equity OfferingSM Sales Agreement, dated as of November 14, 2019, by and between HTG Molecular Diagnostics, Inc. and Cantor Fitzgerald & Co (Filed With SEC on November 15, 2019)

Amended and Restated Non-employee Director Compensation Policy (Filed With SEC on November 12, 2019)

Employment Agreement, dated July 28, 2019, by and between Shaun D. McMeans and the Registrant (Filed With SEC on November 12, 2019)

Underwriting Agreement, dated September 20, 2019, by and among HTG Molecular Diagnostics, Inc. and Cantor Fitzgerald & Co (Filed With SEC on September 23, 2019)

Form of Pre-Funded Warrant to Purchase Shares of Common Stock (Filed With SEC on September 23, 2019)

Securities Purchase Agreement, dated September 20, 2019, by and among HTG Molecular Diagnostics, Inc. and the Purchasers named therein (Filed With SEC on September 23, 2019)

Fourth Amendment to Statement of Work No. 2, dated February 15, 2019, under Master Assay Development, Commercialization and Manufacturing Agreement between the Registrant and... (Filed With SEC on May 9, 2019)

First Amendment to Amended and Restated IVD Test Development and Component Supply Agreement, dated April 23, 2019, by and between Illumina, Inc. and the Registrant (Filed With SEC on May 9, 2019)

HTG Molecular Diagnostics, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on May 9, 2019)

Standard Forms of Stock Option Agreement, Notice of Exercise and Stock Option Grant Notice under the HTG Molecular Diagnostics, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on May 9, 2019)

Forms of Stock Option Agreement, Notice of Exercise and Stock Option Grant Notice for Inducement Award Recipients under the HTG Molecular Diagnostics, Inc. 2014 Equity Incentive... (Filed With SEC on May 9, 2019)

Employment Agreement between the Company and Timothy B. Johnson, dated March 31, 2019 (Filed With SEC on April 2, 2019)

Employment Agreement between the Company and John L. Lubniewski, dated April 1, 2019 (Filed With SEC on April 2, 2019)

Sales Agreement, dated as of March 13, 2019, by and between HTG Molecular Diagnostics, Inc. and Cowen and Company, LLC (Filed With SEC on March 13, 2019)

Second Amendment to Lease Agreement (Suite 100 Administration to include Suite 200), dated January 28, 2019, by and between Pegasus Properties, L.P. and the Registrant (Filed With SEC on March 7, 2019)

HTG Molecular Diagnostics, Inc. Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on November 8, 2018)

First Amendment to Statement of Work No. 2, dated August 7, 2018, under Master Assay Development, Commercialization and Manufacturing Agreement between the Registrant and QIAGEN... (Filed With SEC on November 8, 2018)

Second Amendment to Statement of Work No. 2, dated August 13, 2018, under Master Assay Development, Commercialization and Manufacturing Agreement between the Registrant and QIAGEN... (Filed With SEC on November 8, 2018)

Second Amendment to the Supplement Agreement, dated August 13, 2018, by and among the Registrant, QIAGEN Manchester Limited and Bristol-Myers Squibb Company (Filed With SEC on November 8, 2018)

Third Amendment to Statement of Work No. 2, dated September 27, 2018, under Master Assay Development, Commercialization and Manufacturing Agreement between the Registrant and... (Filed With SEC on November 8, 2018)

First Amendment to Statement of Work No. 3, dated September 21, 2018, under Master Assay Development, Commercialization and Manufacturing Agreement between the Registrant and... (Filed With SEC on November 8, 2018)

Warrant issued to MidCap Funding XXVIII Trust, dated March 26, 2018 (Filed With SEC on May 10, 2018)

Statement of Work No. 3, dated January 12, 2018, under Master Assay Development, Commercialization and Manufacturing Agreement between the Registrant and QIAGEN Manchester Limited (Filed With SEC on May 10, 2018)

Amendment to Statement of Work No. 1, dated December 18, 2017, under Master Assay Development, Commercialization and Manufacturing Agreement between the Registrant and QIAGEN... (Filed With SEC on March 23, 2018)

Statement of Work No. 2, dated October 26, 2017, under Master Assay Development, Commercialization and Manufacturing Agreement between the Registrant and QIAGEN Manchester Limited (Filed With SEC on March 23, 2018)

Supplement Agreement, dated October 26, 2017, by and among the Registrant, QIAGEN Manchester Limited and Bristol-Myers Squibb Company, as amended (Filed With SEC on March 23, 2018)

Underwriting Agreement, dated January 18, 2018, by and among HTG Molecular Diagnostics, Inc. and Leerink Partners LLC and Cantor Fitzgerald & Co., as representatives of the... (Filed With SEC on January 19, 2018)

Subordinated Convertible Promissory Note, dated October 26, 2017, by and between the Company and Qiagen North American Holdings, Inc (Filed With SEC on October 27, 2017)

[Remainder of Page Intentionally Blank] (Filed With SEC on August 8, 2017)

AMENDED AND RESTATED IVD TEST development AND COMPONENT SUPPLY AGREEMENT (Filed With SEC on August 8, 2017)

First Amendment to Master Assay Development, Commercialization and Manufacturing Agreement (Filed With SEC on August 8, 2017)

Statement of Work No. One (Filed With SEC on August 8, 2017)

Master Assay Development, Commercialization and Manufacturing Agreement (Filed With SEC on March 23, 2017)

STOCK PURCHASE AGREEMENT (Filed With SEC on March 23, 2017)

HTG MOLECULAR DIAGNOSTICS, INC. AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on August 9, 2016)

SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on August 9, 2016)

HTG Molecular Diagnostics, Inc. Amended and Restated Stock Purchase Plan Adopted by the Board of Directors: December 1, 2015 Amended by the Board of Directors: January 21, 2016 (Filed With SEC on August 9, 2016)

WARRANT TO PURCHASESTOCK (Filed With SEC on March 31, 2016)

FIRST AMENDMENT TO LEASE AGREEMENT (Suite 100 - Administration) (Filed With SEC on November 12, 2015)

FIRST AMENDMENT TO LEASE AGREEMENT (Suite 300 - Laboratory) (Filed With SEC on November 12, 2015)

HTG MOLECULAR DIAGNOSTICS, INC. (a Delaware corporation) [] Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 28, 2015)

HTG MOLECULAR DIAGNOSTICS, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on April 28, 2015)

HTG MOLECULAR DIAGNOSTICS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:DECEMBER 2, 2014 AMENDED BY THE BOARDOF DIRECTORS: APRIL 23, 2015 APPROVED BYTHE... (Filed With SEC on April 28, 2015)

HTG MOLECULAR DIAGNOSTICS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:DECEMBER 2, 2014 AMENDED BY THE BOARDOF DIRECTORS: APRIL 23, 2015 APPROVED... (Filed With SEC on April 28, 2015)

HTG MOLECULAR DIAGNOSTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on April 28, 2015)

HTG MOLECULAR DIAGNOSTICS, INC. WARRANT TO PURCHASE STOCK (Filed With SEC on February 25, 2015)

INDEMNITY AGREEMENT (Filed With SEC on February 25, 2015)

EXHIBIT A RELEASE AGREEMENT (Tobe signed on or after the Separation Date) (Filed With SEC on February 25, 2015)

HTG MOLECULAR DIAGNOSTICS, INC. NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on February 25, 2015)

ASSET PURCHASE AGREEMENT By andbetween NEOGEN, L.L.C. STEPHEN FELDER RICHARD KRIS and HIGH THROUGHPUT GENOMICS,INC. JANUARY 9, 2001 ASSET PURCHASE AGREEMENT (Filed With SEC on December 30, 2014)

COMMON STOCK WARRANT TOPURCHASE COMMON STOCK OF HIGH THROUGHPUT GENOMICS, INC. (Filed With SEC on December 30, 2014)

WARRANT TO PURCHASE STOCK (Filed With SEC on December 30, 2014)

WARRANT TO PURCHASESTOCK (Filed With SEC on December 30, 2014)

HTG MOLECULAR DIAGNOSTICS, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on December 30, 2014)

HIGH THROUGHPUT GENOMICS, INC. 2001 STOCK OPTION PLAN (Filed With SEC on December 30, 2014)

HTG MOLECULAR DIAGNOSTICS, INC. 2011 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:MARCH 15, 2011 APPROVED BY THE STOCKHOLDERS:MARCH 15, 2011 AMENDED BY THE BOARDOF... (Filed With SEC on December 30, 2014)

STANDARD COMMERCIAL-INDUSTRIAL MULTI TENANT TRIPLENET LEASE BASIC TERMS SHEET (Filed With SEC on December 30, 2014)

STANDARD COMMERCIAL-INDUSTRIAL MULTI TENANT TRIPLE NETLEASE BASIC TERMS SHEET (Filed With SEC on December 30, 2014)

SPONSORED RESEARCH AGREEMENT (Filed With SEC on December 30, 2014)

LOAN AND SECURITY AGREEMENT (Filed With SEC on December 30, 2014)

TERMINATION OF SECURITY AGREEMENT, RELEASE OF SECURITY INTEREST AND UNDERSTANDING REGARDING ASSET PURCHASE AGREEMENT (Filed With SEC on December 30, 2014)

IVD TESTDEVELOPMENT AND COMPONENT SUPPLY AGREEMENT (Filed With SEC on December 30, 2014)

Category

Industry

Companies

Contracts

HTG MOLECULAR DIAGNOSTICS, INC Contracts & Agreements